BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3055181)

  • 1. Some properties of Serratia marcescens, Salmonella paratyphi A, and Enterobacter cloacae with non-enzyme-dependent multiple resistance to beta-lactam antibiotics, aminoglycosides, and quinolones.
    Dang P; Gutmann L; Quentin C; Williamson R; Collatz E
    Rev Infect Dis; 1988; 10(4):899-904. PubMed ID: 3055181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 1. Molecular and genetic characterization of R-factors (author's transl)].
    Schmid B; Kayser FH
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):371-83. PubMed ID: 779353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.
    Sanders CC; Sanders WE; Goering RV; Werner V
    Antimicrob Agents Chemother; 1984 Dec; 26(6):797-801. PubMed ID: 6098219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of beta-lactamases and outer membrane proteins in multiple beta-lactam resistance of Enterobacter cloacae.
    Werner V; Sanders CC; Sanders WE; Goering RV
    Antimicrob Agents Chemother; 1985 Apr; 27(4):455-9. PubMed ID: 3873897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 2. Mechanism of resistance (author's transl)].
    Schmid B; Kayser FH
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):384-92. PubMed ID: 779354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro emergence of quinolone-resistant mutants of Escherichia coli, Enterobacter cloacae, and Serratia marcescens.
    Watanabe M; Kotera Y; Yosue K; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1990 Jan; 34(1):173-5. PubMed ID: 2183709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of outer-membrane proteins in beta-lactam-resistant mutants of Enterobacter cloacae.
    Aggeler R; Then RL; Ghosh R
    J Gen Microbiol; 1987 Dec; 133(12):3383-92. PubMed ID: 3503923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiply-resistant (marA) type strains.
    Piddock LJ; Hall MC; Walters RN
    J Antimicrob Chemother; 1991 Aug; 28(2):185-98. PubMed ID: 1663926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiply resistant mutants of Enterobacter cloacae selected by beta-lactam antibiotics.
    Then RL; Angehrn P
    Antimicrob Agents Chemother; 1986 Nov; 30(5):684-8. PubMed ID: 3492174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outer membrane protein alterations in Serratia marcescens resistant against aminoglycoside and beta-lactam antibiotics.
    Traub WH; Bauer D
    Chemotherapy; 1987; 33(3):172-6. PubMed ID: 3297527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro emergence of simultaneous resistance to both beta-lactam and aminoglycoside antibiotics in a strain of Serratia marcescens.
    Goldstein FW; Gutmann L; Williamson R; Collatz E; Acar JF
    Ann Microbiol (Paris); 1983; 134A(3):329-37. PubMed ID: 6357025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia.
    Gutmann L; Williamson R; Moreau N; Kitzis MD; Collatz E; Acar JF; Goldstein FW
    J Infect Dis; 1985 Mar; 151(3):501-7. PubMed ID: 2982966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection frequency of resistant variants by various beta-lactam antibiotics in clinical Enterobacter cloacae isolates.
    Büscher KH; Cullmann W; Dick W; Stieglitz M
    Chemotherapy; 1987; 33(1):40-51. PubMed ID: 3493886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
    Ramadan MA; Tawfik AF; Shibl AM
    Chemotherapy; 1995; 41(3):193-9. PubMed ID: 7656665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of clavulanic acid and other beta-lactam antibiotics against strains of Pseudomonas aeruginosa, Serratia marcescens and other bacteria.
    Rogers DT; Russell AD
    J Appl Bacteriol; 1980 Aug; 49(1):111-8. PubMed ID: 6776086
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.
    Ku YH; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2008 Aug; 41(4):332-6. PubMed ID: 18787741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of synergistic effects of beta-lactam antibiotic combinations on gram-negative bacilli.
    Farrar WE; Newsome JK
    Antimicrob Agents Chemother; 1973 Aug; 4(2):109-14. PubMed ID: 4598215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emergence of beta-lactam resistance among strains of Enterobacter cloacae and Pseudomonas aeruginosa.
    Aronoff SC
    Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S100-3; discussion S128-32. PubMed ID: 2510122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic susceptibility and beta-lactamase production in clinical isolates of Enterobacter spp.
    Lindh E; Dornbusch K; Jalakas K; Forsgren A
    APMIS; 1990 May; 98(5):462-70. PubMed ID: 2162681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens.
    Sanders CC; Watanakunakorn C
    J Infect Dis; 1986 Mar; 153(3):617-9. PubMed ID: 3512733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.